These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 877399)

  • 21. The presence of the type A form of monoamine oxidase within nigrostriatal dopamine-containing neurons.
    Demarest KT; Smith DJ; Azzaro AJ
    J Pharmacol Exp Ther; 1980 Nov; 215(2):461-8. PubMed ID: 7441510
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proceedings: Changes in the MAO activity with age in the rat vas deferens.
    Callingham BA; Lyles GA
    Br J Pharmacol; 1975 Oct; 55(2):305P. PubMed ID: 1201430
    [No Abstract]   [Full Text] [Related]  

  • 23. Monoamine oxidase of rat skeletal muscle: substrate specificity and half-life.
    Kwatra MM; Sourkes TL
    Life Sci; 1980 Dec; 27(24):2327-31. PubMed ID: 7207021
    [No Abstract]   [Full Text] [Related]  

  • 24. [Inhibition of monoamine oxidase A and B in the heart and brain of the rat with amitriptyline, pargyline and pirlindol].
    Schraven E; Reibert R
    Arzneimittelforschung; 1984; 34(10):1258-60. PubMed ID: 6542783
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A comparison of the pharmacology of (-)-deprenyl to N-methylpropargylamine-1-aminoindane (J-508) and rasagiline, the desmethyl-analogue of J-508].
    Miklya I
    Neuropsychopharmacol Hung; 2008 Mar; 10(1):15-22. PubMed ID: 18771016
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clorgyline and deprenyl insensitive monoamine oxidase in rat brain soluble fraction.
    Shekhar C; Mayanil K; Baquer NZ
    Biochem Pharmacol; 1982 Dec; 31(23):3925-7. PubMed ID: 6818972
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monoamine oxidase in rat reticulocytes: subcellular localization and identification of isoenzymes.
    Quiring K; Hubertus S
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Nov; 300(3):273-9. PubMed ID: 202882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiple forms of monoamine oxidase in developing chick brain.
    Suzuki O; Katsumata Y; Oya M; Asano M
    Dev Neurosci; 1978; 1(3-4):172-6. PubMed ID: 756381
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential postnatal development of monoamine oxidases A and B in the blood-brain barrier of the rat.
    Kalaria RN; Harik SI
    J Neurochem; 1987 Nov; 49(5):1589-94. PubMed ID: 3117975
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The nature of inhibition of cat brain mitochondrial monoamine oxidase by clorgyline.
    Youdim MB; Holman B
    J Neural Transm; 1975; 37(1):11-24. PubMed ID: 1159411
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of type A monoamine oxidase by coptisine in mouse brain.
    Ro JS; Lee SS; Lee KS; Lee MK
    Life Sci; 2001 Dec; 70(6):639-45. PubMed ID: 11833714
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selectivity of clorgyline and pargyline as inhibitors of monoamine oxidases A and B in vivo in man.
    Murphy DL; Lipper S; Slater S; Shiling D
    Psychopharmacology (Berl); 1979 Apr; 62(2):129-32. PubMed ID: 111275
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Beta-phenylethylamine and benzylamine as substrates for human monoamine oxidase A: A source of some anomalies?
    Lewinsohn R; Glover V; Sandler M
    Biochem Pharmacol; 1980 Mar; 29(5):777-81. PubMed ID: 20227955
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [3H]tryptamine binding sites are not identical to monoamine oxidase in rat brain.
    Perry DC; Grimm LJ; Kettler KG; Kellar KJ
    J Neurochem; 1988 Nov; 51(5):1535-40. PubMed ID: 3139835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition by pargyline of cardiovascular amine oxidase activity.
    Fuentes JA; Neff NH
    Biochem Pharmacol; 1977 Nov; 26(22):2107-12. PubMed ID: 588291
    [No Abstract]   [Full Text] [Related]  

  • 36. An explanation for deamination of phenylethylamine by multiple types of monoamine oxidase.
    Dial EJ; Clarke DE
    Pharmacol Res Commun; 1979 Jun; 11(6):491-500. PubMed ID: 504323
    [No Abstract]   [Full Text] [Related]  

  • 37. A simple method for screening monoamine oxidase (MAO) inhibitory drugs for type preference.
    Dorris RL
    J Pharmacol Methods; 1982 Mar; 7(2):133-7. PubMed ID: 7098495
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monoamine oxidase activity in embryos of pike (Esox lucius).
    Senatori O; Nicotra A; Scopelliti R
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1990; 96(1):87-90. PubMed ID: 1980887
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of serotonin oxidation as a component of the altered substrate specificity in the Y444F mutant of recombinant human liver MAO A.
    Nandigama RK; Miller JR; Edmondson DE
    Biochemistry; 2001 Dec; 40(49):14839-46. PubMed ID: 11732903
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The oxidation of dopamine by the semicarbazide-sensitive amine oxidase (SSAO) from rat vas deferens.
    Lizcano JM; Balsa D; Tipton KF; Unzeta M
    Biochem Pharmacol; 1991 Apr; 41(8):1107-10. PubMed ID: 2009089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.